Table 1 Patients’ demographic data and anemia status at transplant and at each year of follow-up
Year post-transplant | 0 | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|---|
Total (n) | 154 | 140 | 136 | 128 | 126 | 118 |
Age (years) | 38.1 ± 10.3 | 38.8 ± 10.4 | 39.9 ± 10.4 | 40.0 ± 9.9 | 41.1 ± 9.9 | 41.9 ± 10.0 |
Gender (male/female) | 109/45 | 98/42 | 97/39 | 89/39 | 89/37 | 85/33 |
Immunosuppressive | ||||||
CsA + AZT + pred | 30 (19.5%) | 25 (17.9%) | 20 (14.7%) | 17 (13.3%) | 16 (12.7%) | 14 (11.9%) |
CsA + MMF + pred | 89 (57.8%) | 81 (58.6%) | 84 (61.8%) | 80 (62.5%) | 79 (62.7%) | 73 (61.9%) |
Tac + MMF + pred | 32 (20.8%) | 31 (22.1%) | 30 (22.1%) | 29 (22.7%) | 29 (23.0%) | 29 (24.6%) |
Tac + AZT + pred | 3 (1.9%) | 2 (2%) | 2 (1.5%) | 2 (1.6%) | 2 (1.6%) | 2 (1.7%) |
Mean Hb (g/dL) | 11.5 ± 1.5 | 13.7 ± 1.9 | 13.7 ± 1.8 | 13.5 ± 1.9 | 13.4 ± 1.9 | 13.0 ± 2.0 |
Anemic | ||||||
n | 70 | 15 | 13 | 19 | 17 | 23 |
Percentage | 45.5% | 10.7% | 9.6% | 14.8% | 13.5% | 19.6% |